Protect Pharmaceutical Corporation
Protect Pharmaceutical Corporation
Your view on PRTT
Overview
What the company does, where it operates, and who runs it.
About Protect Pharmaceutical Corporation
- Industry
- Airlines, Airports & Air Services
- Sector
- Industrials
- CEO
- Alan Crooks
- Headquarters
- 4876 Cecile Avenue, Las Vegas, NV, US
- Industry
- Airlines, Airports & Air Services
- Sector
- Industrials
- CEO
- Alan Crooks
- Headquarters
- 4876 Cecile Avenue, Las Vegas, NV, US
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties.
The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Protect Pharmaceutical Corporation, and the rating behind it. PRTT last traded at $0.07; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Protect Pharmaceutical Corporation. Starting points for Protect Pharmaceutical Corporation: beta 2.77 — an Airlines, Airports & Air Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Protect Pharmaceutical Corporation. Protect Pharmaceutical Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Protect Pharmaceutical Corporation. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Protect Pharmaceutical Corporation. Protect Pharmaceutical Corporation has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Protect Pharmaceutical Corporation valued side by side against its closest peers. Protect Pharmaceutical Corporation is measured against Airlines, Airports & Air Services peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Protect Pharmaceutical Corporation, and how their positions are changing. At a $4.3M market value, institutional positions materially move Protect Pharmaceutical Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Protect Pharmaceutical Corporation executives and directors. Shares of Protect Pharmaceutical Corporation have traded between $0.02 and $1.69 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Protect Pharmaceutical Corporation. Protect Pharmaceutical Corporation is a $4.3M Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Protect Pharmaceutical Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Protect Pharmaceutical Corporation. Coverage tracks Protect Pharmaceutical Corporation within Airlines, Airports & Air Services (Industrials). Press releases and market coverage, newest first.